FHC — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

FHC is a long-established, private medical device company focused on high-precision targeting systems for neuromodulation and neurosurgery. Its technology platform supports therapies for movement disorders like Parkinson's Disease, Epilepsy, and Essential Tremor, as well as research applications. The company operates with a direct sales and partnership model, recently gaining FDA clearance for new products and expanding its software ecosystem through collaborations.

Parkinson’s DiseaseEpilepsyDystoniaEssential TremorMovement Disorders

Technology Platform

Integrated neural microTargeting platform comprising stereotactic navigation (STarFix, WayPoint), neuromodulation systems (Guideline), electrophysiology recording/microdrive hardware (NeuroCraft), and clinical/research data acquisition software (NeuraLynx).

Opportunities

Expansion into the clinical epilepsy monitoring unit (EMU) market with the newly FDA-cleared ATLAS Stim Headbox.

Growing demand for minimally invasive, patient-specific stereotactic procedures (e.g., laser ablation, SEEG) favors adoption of the STarFix platform.

Strategic software partnerships can create a more locked-in, comprehensive ecosystem for functional neurosurgeons.

Risk Factors

Competition from larger, integrated medical device companies with substantial sales and R&D resources.

Market growth is dependent on the adoption rate of advanced functional neurosurgery techniques by a limited pool of neurosurgeons.

Complex and variable reimbursement landscapes for capital equipment and disposable patient-specific platforms.

Competitive Landscape

FHC competes in specialized segments against giants like Medtronic (DBS, StealthStation), Boston Scientific, and Abbott (St. Jude Medical), as well as other stereotactic/navigation companies such as Brainlab, Inomed, and Renishaw. Its differentiation lies in its focused microTargeting expertise, frameless STarFix system, and integrated hardware/software platform for both clinical and research applications.

More companies in Neuroscience & CNS →More companies in United States →